Want to join the conversation?
$CSC FY15 10-K: In FY15, divested a software business within GBS segment. US dollar strengthened against most major world currencies resulting in $204MM adverse effect on cash and cash equivalents. During FY15, the Company repurchased 11,715,551 shares for a total consideration of $736MM, at a weighted average price of $62.83.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.